Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

The development of an efficacious vaccine against norovirus is of paramount importance given its potential to reduce the global burden of norovirus-associated morbidity and mortality. Here, we report a detailed immunological analysis of a phase I, double-blind, placebo-controlled clinical trial perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Waerlop, Gwenn, Janssens, Yorick, Jacobs, Bart, Jarczowski, Franziska, Diessner, André, Leroux-Roels, Geert, Klimyuk, Victor, Leroux-Roels, Isabel, Thieme, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331465/
https://www.ncbi.nlm.nih.gov/pubmed/37435073
http://dx.doi.org/10.3389/fimmu.2023.1188431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331465/
https://www.ncbi.nlm.nih.gov/pubmed/37435073
http://dx.doi.org/10.3389/fimmu.2023.1188431

Ejemplares similares